NAOV צמיחת הכנסות רבעונית NanoVibronix Inc.

NanoVibronix, Inc. (NAOV) relies on a strong team of ultrasound engineers and clinical experts. A fabless production model in Asia complemented by US logistics enhances this potential. The percentage change in quarterly revenue visualizes income dynamics, where the value 92.80 shows the current figure. A stable cash flow is ensured by the installation of wound-healing devices, which guarantees regular payments for ancillary services.
פילוחי נתונים אנליטיים מרוכזים עבור nanovibronix.com (NAOV)

For NanoVibronix, Inc., whose FDA-cleared proprietary devices face medical market inertia, the quarterly revenue growth history serves as an indicator of the actual speed of technology commercialization. This metric measures the percentage change in sales volume for the current quarter compared to the same period last year, allowing investors to assess cash flow sustainability and the risk of overpaying for a slowing business within a narrow niche.